Literature DB >> 20048198

Syndecan-1 amplifies angiotensin II-induced cardiac fibrosis.

Mark W M Schellings1, Davy Vanhoutte, Geert C van Almen, Melissa Swinnen, Joost J G Leenders, Nard Kubben, Rick E W van Leeuwen, Leo Hofstra, Stephane Heymans, Yigal M Pinto.   

Abstract

Syndecan-1 (Synd1) is a transmembrane heparan sulfate proteoglycan that functions as a coreceptor for various growth factors and modulates signal transduction. The present study investigated whether Synd1, by affecting growth factor signaling, may play a role in hypertension-induced cardiac fibrosis and dysfunction. Expression of Synd1 was increased significantly in mouse hearts with angiotensin II-induced hypertension, which was spatially related to cardiac fibrosis. Angiotensin II significantly impaired fractional shortening and induced cardiac fibrosis in wild-type mice, whereas these effects were blunted in Synd1-null mice. Angiotensin II significantly increased cardiac expression of connective tissue growth factor and collagen type I and III in wild-type mice, which was blunted in Synd1-null mice. These findings were confirmed in vitro, where angiotensin II induced the expression of both connective tissue growth factor and collagen I in fibroblasts. The absence of Synd1 in either Synd1-null fibroblasts, after knockdown of Synd1 by short hairpin RNA, or after inhibition of heparan sulfates by protamine attenuated this increase, which was associated with reduced phosphorylation of Smad2. In conclusion, loss of Synd1 reduces cardiac fibrosis and dysfunction during angiotensin II-induced hypertension.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20048198     DOI: 10.1161/HYPERTENSIONAHA.109.137885

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  29 in total

Review 1.  Matricellular proteins in cardiac adaptation and disease.

Authors:  Nikolaos G Frangogiannis
Journal:  Physiol Rev       Date:  2012-04       Impact factor: 37.312

Review 2.  Molecular functions of syndecan-1 in disease.

Authors:  Yvonne Hui-Fang Teng; Rafael S Aquino; Pyong Woo Park
Journal:  Matrix Biol       Date:  2011-10-18       Impact factor: 11.583

Review 3.  Heparan sulfate proteoglycans.

Authors:  Stephane Sarrazin; William C Lamanna; Jeffrey D Esko
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

4.  Extracellular superoxide dismutase protects cardiovascular syndecan-1 from oxidative shedding.

Authors:  Corrine R Kliment; Tim D Oury
Journal:  Free Radic Biol Med       Date:  2011-02-18       Impact factor: 7.376

Review 5.  Endothelial Glycocalyx as Biomarker for Cardiovascular Diseases: Mechanistic and Clinical Implications.

Authors:  Youn-Hyun Kim; Petra Nijst; Kathryn Kiefer; W H Wilson Tang
Journal:  Curr Heart Fail Rep       Date:  2017-04

Review 6.  MicroRNAs: a new piece in the paediatric cardiovascular disease puzzle.

Authors:  Ahmed Omran; Dalia Elimam; Keith A Webster; Lina A Shehadeh; Fei Yin
Journal:  Cardiol Young       Date:  2013-02-26       Impact factor: 1.093

7.  Angiotensin II induced differentially expressed microRNAs in adult rat cardiac fibroblasts.

Authors:  Xiaoying Jiang; Qilan Ning; Juanli Wang
Journal:  J Physiol Sci       Date:  2012-09-25       Impact factor: 2.781

8.  Syndecan-1: a critical mediator in cardiac fibrosis.

Authors:  Nikolaos G Frangogiannis
Journal:  Hypertension       Date:  2010-01-04       Impact factor: 10.190

9.  Endothelial dysfunction is a superinducer of syndecan-4: fibrogenic role of its ectodomain.

Authors:  Mark Lipphardt; Jong W Song; Brian B Ratliff; Hassan Dihazi; Gerhard A Müller; Michael S Goligorsky
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-11-03       Impact factor: 4.733

10.  Angiotensin II upregulated the expression of microRNA-224 but not microRNA-21 in adult rat cardiac fibroblasts.

Authors:  Qilan Ning; Xiaoying Jiang
Journal:  Biomed Rep       Date:  2013-07-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.